Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Miller

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Current Medical Research and Opinion|October 3, 2007
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosisDouglas S Goodin, Louis D Biermann, Saeed Bohlega, et al.
Annals of Neurology|April 25, 2006
Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosisHillel S Panitch, Ronald A Thisted, Richard A Smith, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravisNili Avidan, Rozen Le Panse, Hanne F Harbo, et al.
The Lancet. Neurology|July 23, 2011
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringLudwig Kappos, David Bates, Gilles Edan, et al.
ACS Nano|December 22, 2016
Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled MoleculesMorad K Nakhleh, Haitham Amal, Raneen Jeries, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Current Medical Research and Opinion|October 3, 2007
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosisDouglas S Goodin, Louis D Biermann, Saeed Bohlega, et al.
Annals of Neurology|April 25, 2006
Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosisHillel S Panitch, Ronald A Thisted, Richard A Smith, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravisNili Avidan, Rozen Le Panse, Hanne F Harbo, et al.
The Lancet. Neurology|July 23, 2011
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringLudwig Kappos, David Bates, Gilles Edan, et al.
ACS Nano|December 22, 2016
Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled MoleculesMorad K Nakhleh, Haitham Amal, Raneen Jeries, et al.
Pageof 10